Abstract
This chapter provides a brief review of methodologies and software solutions for several types of adaptive designs: the traditional and adaptive group sequential designs including sample size reestimation, multistage adaptive designs with arm and subpopulation selection at interim analyses, and adaptive designs for dose-finding studies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anderson KM (2007) Optimal spending functions for asymmetric group sequential designs. Biom J 49(3):337–345
Anderson KM, Clark JB (2010) Fitting spending functions. Stat Med 29(3):321–327
Armitage P, McPherson CK, Rowe BC (1969) Repeated significance tests on accumulating data. J Roy Stat Soc A 132:235–244
Bauer P (1989) Multistage testing with adaptive designs. Biom Inform Med Biol 20:130–148
Bauer P, Kieser M (1999) Combining different phases in the development of medical treatments within a single trial. Stat Med 18:1833–1848
Bauer P, Brannath W, Posch M (2001) Flexible two stage designs: an overview. Methods Inf Med 40:117–121
Berry SM, Carroll RJ, Ruppert D (2002) Bayesian smoothing and regression splines for measurement error problems. J Am Stat Assoc 97:160–169
Bornkamp B, Bretz F, Dmitrienko A, Enas G, Gaydos B, Hsu CH, Koenig F, Krams M, Liu Q, Neuenschwander B, Parke T, Pinheiro J, Roy A, Sax R, Shen F (2007) Innovative approaches for designing and analyzing adaptive dose-ranging trials (with discussion). J Biopharm Stat 17:965–995
Bornkamp B, Pinheiro JC, Bretz F (2009) MCPMod: an R package for the design and analysis of dose-finding studies. J Stat Software 29(7):1–23
Bornkamp B, Bretz F, Dette H, Pinheiro JC (2011) Response-adaptive dose-finding under model uncertainty. Ann Appl Stat 5:1611–1631
Brannath W, Posch M, Bauer P (2002) Recursive combination tests. J Am Stat Assoc 97:236–244
Brannath W, Zuber E, Branson M, Bretz F, Gallo P, Posch M, Racine-Poon A (2009) Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Stat Med 28:1445–1463
Bretz F, Pinheiro J, Branson M (2005) Combining multiple comparisons and modeling techniques in dose–response studies. Biometrics 61:738–748
Bretz F, Koenig F, Brannath W, Glimm E, Posch M (2009) Adaptive designs for confirmatory clinical trials. Stat Med 28:1181–1217
Cui L, Hung HMJ, Wang S-J (1999) Modification of sample size in group sequential clinical trials. Biometrics 55:853–857
Dmitrienko A, Tamhane AC (2009) Gatekeeping procedures in clinical trials. In: Dmitrienko A, Tamhane AC, Bretz F (eds) Multiple testing problems in pharmaceutical statistics. Chapman and Hall/CRC Press, New York, NY
Dragalin V, Bornkamp B, Bretz F, Miller F, Padmanabhan SK, Perevozskaya I, Pinheiro J, Smith JR (2010) A simulation study to compare new adaptive dose-ranging designs. Stat Biopharm Res 2:487–512
Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121
Emerson SS, Fleming TR (1989) Symmetric group sequential test designs. Biometrics 45:905–923
Friede T, Stallard N (2008) A comparison of methods for adaptive treatment selection. Biom J 50:767–781
Friede T, Parsons N, Stallard N, Todd S, Valdes-Marquez E, Chataway J, Nicholas R (2011) Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis. Stat Med 30:1528–1540
Ivanova A (2006) Escalation, up-and-down and A + B designs for dose-finding trials. Stat Med 25:3668–3678
Ivanova A, Bolognese JA, Perevozskaya I (2008) Adaptive dose finding based on t-statistic for dose–response trials. Stat Med 27:1581–1592
Jennison C, Turnbull BW (2000) Group sequential methods with applications to clinical trials. Chapman & Hall/CRC, Boca Raton
Kieser M, Bauer P, Lehmacher W (1999) Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biom J 41:261–277
Kim K, DeMets DL (1987) Design and analysis of group sequential tests based on the Type I error spending rate function. Biometrika 74:149–154
Koenig F, Brannath W, Bretz F, Posch M (2008) Adaptive Dunnett tests for treatment selection. Stat Med 27:1612–1625
Lachin JM (2005) A review of methods for futility stopping based on conditional power. Stat Med 24:2747–2764
Lan KKG, DeMets DL (1983) Discrete sequential boundaries for clinical trials. Biometrika 70:659–663
Lehmacher W, Wassmer G (1999) Adaptive sample size calculations in group sequential trials. Biometrics 55:1286–1290
Marcus R, Peritz E, Gabriel KR (1976) On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63:655–660
Muller H-H, Schafer H (2001) Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 57:886–891
Pampallona S, Tsiatis AA (1994) Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. J Stat Plann Infer 42:19–35
Parsons N, Friede T, Todd S, Valdes-Marquez E, Chataway J, Nicholas R, Stallard N (2012) An R package for implementing simulations for seamless phase II/III clinical trials using early outcomes for treatment selection. Comput Stat Data Anal 56:1150–1160
Posch M, Bauer P, Brannath W (2003) Issues in designing flexible trials. Stat Med 22:953–969
Posch M, Koenig F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P (2005) Testing and estimation in flexible group sequential designs with adaptive treatment selection. Stat Med 24:3697–3714
Proschan MA, Hunsberger SA (1995) Designed extension of studies based on conditional power. Biometrics 51:1315–1324
Robertson T, Wright FT, Dykstra RL (1988) Order restricted statistical inference. Wiley, New York, NY
Stallard N, Friede T (2008) A group-sequential design for clinical trials with treatment selection. Stat Med 27:6209–6227
Temple R (1994) Special study designs: early escape, enrichment, studies in non-responders. Comm Stat Theor Meth 23:499–531
Temple R (2005) Enrichment designs: efficiency in development of cancer treatments. J Clin Oncol 23:4838–4839
Tukey JW, Ciminera JL, Heyse JF (1985) Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41:295–301
Wang S-J, Hung HMJ, O'Neill RT (2009) Adaptive patient enrichment designs in therapeutic trials. Biom J 51(2):358–374
Wassmer G (2006) Planning and analyzing adaptive group sequential survival trials. Biom J 48:714–729
Wassmer G, Vandemeulebroecke M (2006) A brief review on software developments for group sequential and adaptive designs. Biom J 48(4):732–737
West M, Harrison J (1997) Bayesian forecasting and dynamic models, 2nd edn. Springer, New York, NY
Zhu L, Ni L, Yao B (2011) Group sequential methods and software applications. Am Stat 65(3):127–135
Acknowledgments
The author would like to thank Steve Ascher for his help with writing this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tymofyeyev, Y. (2014). A Review of Available Software and Capabilities for Adaptive Designs. In: He, W., Pinheiro, J., Kuznetsova, O. (eds) Practical Considerations for Adaptive Trial Design and Implementation. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1100-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1100-4_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1099-1
Online ISBN: 978-1-4939-1100-4
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)